You searched for "evidence"

1714 results found

Dupilumab prospective RCT for CRSwNP, a multinational trial of 60 patients with a 16-week CT follow-up

This transcontinental work describes a randomised, double blind, placebo controlled parallel group study over a 16-week period, assessing 60 patients with CRSwNP by CT scan scores. All patients had a four-week period of intranasal corticosteroids followed by randomisation to add...

Liver function assessment in glandular fever

This month’s Editors’ Choice is a systematic review of the role of liver assessment in patients with glandular fever. Admission of patients with sore throat constitutes a significant burden of acute work for paediatric and adult ENT services as well...

MRI scanning patients with cochlear implants and auditory brainstem implants

In the last five to six decades, MRI scanning has gone from physics experiments in Nottingham University through to Nobel prize-winning work by Sir Peter Mansfield and Paul Lauterbur, to a ‘routine’ imaging modality with an estimated 60 million MRI...

Misophonia

Decreased sound tolerance is a common audiologic complaint. Unlike the classic characteristics of hyperacusis whereby a patient is sensitive to the frequency or volume of a sound, misophonia is a strong emotional and psychological reaction to a sound with a...

Secrets of the listening brain: what measuring the brain can tell us about hearing aid use and more

In a typical audiology clinic, on any given day, a person is waiting to see an audiologist to get a hearing aid (HA). It might have taken over 10 years to get to this point of considering a hearing aid(s)...

New Widex Study On Fractal Sound Stimulation in Hearing Aids Shows Positive Effects for Tinnitus Treatment and Overall Well-Being

Widex USA Inc. has published preliminary results of an ongoing study that validates the use of fractal sound stimulation, specifically new Widex SoundRelax tones, in treating tinnitus and supporting relaxation, concentration and well-being for all Widex wearers.

Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device

Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...

Allergy – what’s in a name?

Allergy is defined as an “abnormal immune reaction to an ordinarily harmless substance” [1], however the meaning of the word has taken many forms since its introduction in 1906 by Austrian Paediatrician and Immunologist, Clemens von Pirquet [2]. Combining his...

The fatal illness of Frederick the Noble

Sir Morell Mackenzie is acknowledged as the ‘Father of British Otolaryngology’. He was the leading throat specialist of his time and one of the founders of the Journal of Laryngology and Otology in 1887. He studied in Paris, Vienna and...

The risks of misjudging African American dialects as lesser!

Healthcare inequalities in multicultural societies, such as the UK, are becoming increasingly apparent. They arise via a complex interplay of factors, with socioeconomic deprivation, structural biases and specific cultural and biological risk factors all contributing to disparities. There is ample...

In memory of Iain Swan 1952–2025

Iain Swan. Iain Swan was a Senior Lecturer in Otorhinolaryngology, University of Glasgow and Consultant Otorhinolaryngologist, Glasgow Royal Infirmary and Scottish Section MRC Institute of Hearing Research 1986-2016. Iain had a happy childhood growing up in Carbeth and attended school...

Robotic‑assisted cochlear implant insertion approved by FDA

The Minnesota-based medical technology company iotaMotion has announced a "meaningful milestone in peadiatric hearing care", having received clearance from the US Food and Drug Administration (FDA) for the iotaSoft® robotic‑assisted cochlear implant insertion system for children aged four and older.